Phreesia Inc (PHR)
22.26
+1.25
(+5.95%)
USD |
NYSE |
May 02, 16:00
22.24
-0.02
(-0.09%)
After-Hours: 20:00
Phreesia Cash from Financing (TTM): -17.12M for Jan. 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -17.12M |
October 31, 2023 | -22.91M |
July 31, 2023 | -24.29M |
April 30, 2023 | -24.02M |
January 31, 2023 | -20.80M |
October 31, 2022 | -18.33M |
July 31, 2022 | -15.09M |
April 30, 2022 | -13.27M |
January 31, 2022 | 234.97M |
October 31, 2021 | 217.47M |
July 31, 2021 | 392.19M |
Date | Value |
---|---|
April 30, 2021 | 393.82M |
January 31, 2021 | 150.66M |
October 31, 2020 | 176.91M |
July 31, 2020 | 0.51M |
April 30, 2020 | 96.32M |
January 31, 2020 | 100.27M |
October 31, 2019 | 106.06M |
July 31, 2019 | 107.91M |
April 30, 2019 | 9.947M |
January 31, 2019 | 4.193M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-24.29M
Minimum
Jul 2023
393.82M
Maximum
Apr 2021
95.86M
Average
96.32M
Median
Apr 2020
Cash from Financing (TTM) Benchmarks
Teladoc Health Inc | 9.252M |
American Shared Hospital Services | 1.91M |
Novo Integrated Sciences Inc | 4.668M |
Astrana Health Inc | 3.421M |
Cryo-Cell International Inc | -0.7611M |